High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy

BACKGROUND: Diffuse large B-cell lymphoma is a clinically and molecularly heterogeneous disease. Gene expression profiling studies have shown that the tumor microenvironment affects survival and that the angiogenesis-related signature is prognostically unfavorable. The contribution of histopathologi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Cardesa-Salzmann, Teresa M., Colomo, Luis, Gutierrez, Gonzalo, Chan, Wing C., Weisenburger, Dennis, Climent, Fina, González-Barca, Eva, Mercadal, Santiago, Arenillas, Leonor, Serrano, Sergio, Tubbs, Ray, Delabie, Jan, Gascoyne, Randy D., Connors, Joseph M, Mate, Jose L., Rimsza, Lisa, Braziel, Rita, Rosenwald, Andreas, Lenz, Georg, Wright, George, Jaffe, Elaine S., Staudt, Louis, Jares, Pedro, López-Guillermo, Armando, Campo, Elias
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ferrata Storti Foundation 2011
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3128218/
https://ncbi.nlm.nih.gov/pubmed/21546504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.037408
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller